Breaking World Pharma News

04.19.2018

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Roche 17 April 2018 Roche Roche (SIX: RO, ROG; OTCQX: RHHBY) today {...}

Read More